12-5952393-C-T

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BA1

This summary comes from the ClinGen Evidence Repository: The NM_000552.4(VWF):c.8113G>A (p.Gly2705Arg) variant in VWF is a missense variant predicted to cause substitution of Glycine by Arginine at amino acid 2705. The Grpmax filtering allele frequency in gnomAD v4.1 is 0.1227 (based on 11352/91062 alleles in the South Asian population, including 829 homozygotes), which is higher than the ClinGen VWD VCEP threshold of >0.1 for BA1. As reported in PMID:26105150 the variant is significantly associated with lower plasma levels of FVIII but not vWF. In summary this variant is classified as Benign for VWD based on the ACMG/AMP criteria applied, as specified by the ClinGen VWD VCEP: BA1 LINK:https://erepo.genome.network/evrepo/ui/classification/CA6401404/MONDO:0019565/090

Frequency

Genomes: 𝑓 0.045 ( 204 hom., cov: 32)
Exomes 𝑓: 0.059 ( 3022 hom. )

Consequence

VWF
NM_000552.5 missense, splice_region

Scores

7
6
5
Splicing: ADA: 0.9526
1
1

Clinical Significance

Benign reviewed by expert panel B:9

Conservation

PhyloP100: 5.94

Publications

27 publications found
Variant links:
Genes affected
VWF (HGNC:12726): (von Willebrand factor) This gene encodes a glycoprotein involved in hemostasis. The encoded preproprotein is proteolytically processed following assembly into large multimeric complexes. These complexes function in the adhesion of platelets to sites of vascular injury and the transport of various proteins in the blood. Mutations in this gene result in von Willebrand disease, an inherited bleeding disorder. An unprocessed pseudogene has been found on chromosome 22. [provided by RefSeq, Oct 2015]
VWF Gene-Disease associations (from GenCC):
  • hereditary von Willebrand disease
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • von Willebrand disease type 2B
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • von Willebrand disease 2
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine
  • von Willebrand disease 1
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
  • von Willebrand disease type 2A
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • von Willebrand disease type 2M
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • von Willebrand disease 3
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • von Willebrand disease type 2N
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BA1
For more information check the summary or visit ClinGen Evidence Repository.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
VWFNM_000552.5 linkc.8113G>A p.Gly2705Arg missense_variant, splice_region_variant Exon 49 of 52 ENST00000261405.10 NP_000543.3 P04275-1
VWFXM_047429501.1 linkc.8113G>A p.Gly2705Arg missense_variant, splice_region_variant Exon 49 of 52 XP_047285457.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
VWFENST00000261405.10 linkc.8113G>A p.Gly2705Arg missense_variant, splice_region_variant Exon 49 of 52 1 NM_000552.5 ENSP00000261405.5 P04275-1
VWFENST00000612016.1 linkn.522G>A splice_region_variant, non_coding_transcript_exon_variant Exon 2 of 3 5
VWFENST00000621700.1 linkn.431G>A non_coding_transcript_exon_variant Exon 4 of 4 3

Frequencies

GnomAD3 genomes
AF:
0.0448
AC:
6807
AN:
152098
Hom.:
204
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0177
Gnomad AMI
AF:
0.0800
Gnomad AMR
AF:
0.0433
Gnomad ASJ
AF:
0.0360
Gnomad EAS
AF:
0.00289
Gnomad SAS
AF:
0.120
Gnomad FIN
AF:
0.0612
Gnomad MID
AF:
0.0601
Gnomad NFE
AF:
0.0568
Gnomad OTH
AF:
0.0449
GnomAD2 exomes
AF:
0.0593
AC:
14897
AN:
251422
AF XY:
0.0641
show subpopulations
Gnomad AFR exome
AF:
0.0172
Gnomad AMR exome
AF:
0.0702
Gnomad ASJ exome
AF:
0.0337
Gnomad EAS exome
AF:
0.00321
Gnomad FIN exome
AF:
0.0595
Gnomad NFE exome
AF:
0.0558
Gnomad OTH exome
AF:
0.0518
GnomAD4 exome
AF:
0.0591
AC:
86371
AN:
1461538
Hom.:
3022
Cov.:
32
AF XY:
0.0611
AC XY:
44423
AN XY:
727068
show subpopulations
African (AFR)
AF:
0.0162
AC:
543
AN:
33472
American (AMR)
AF:
0.0654
AC:
2923
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.0333
AC:
869
AN:
26132
East Asian (EAS)
AF:
0.00202
AC:
80
AN:
39688
South Asian (SAS)
AF:
0.125
AC:
10779
AN:
86244
European-Finnish (FIN)
AF:
0.0591
AC:
3156
AN:
53382
Middle Eastern (MID)
AF:
0.0584
AC:
337
AN:
5768
European-Non Finnish (NFE)
AF:
0.0577
AC:
64182
AN:
1111760
Other (OTH)
AF:
0.0580
AC:
3502
AN:
60380
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
4731
9462
14194
18925
23656
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2434
4868
7302
9736
12170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0447
AC:
6798
AN:
152216
Hom.:
204
Cov.:
32
AF XY:
0.0448
AC XY:
3332
AN XY:
74432
show subpopulations
African (AFR)
AF:
0.0176
AC:
730
AN:
41532
American (AMR)
AF:
0.0432
AC:
661
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.0360
AC:
125
AN:
3470
East Asian (EAS)
AF:
0.00289
AC:
15
AN:
5184
South Asian (SAS)
AF:
0.119
AC:
573
AN:
4818
European-Finnish (FIN)
AF:
0.0612
AC:
649
AN:
10608
Middle Eastern (MID)
AF:
0.0612
AC:
18
AN:
294
European-Non Finnish (NFE)
AF:
0.0568
AC:
3860
AN:
67990
Other (OTH)
AF:
0.0445
AC:
94
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
336
672
1008
1344
1680
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
90
180
270
360
450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0517
Hom.:
968
Bravo
AF:
0.0414
TwinsUK
AF:
0.0593
AC:
220
ALSPAC
AF:
0.0602
AC:
232
ESP6500AA
AF:
0.0197
AC:
87
ESP6500EA
AF:
0.0578
AC:
497
ExAC
AF:
0.0593
AC:
7197
Asia WGS
AF:
0.0530
AC:
186
AN:
3478
EpiCase
AF:
0.0601
EpiControl
AF:
0.0566

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

not specified Benign:3
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary von Willebrand disease Benign:2
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 13, 2024
ClinGen von Willebrand Disease Variant Curation Expert Panel, ClinGen
Significance:Benign
Review Status:reviewed by expert panel
Collection Method:curation

The NM_000552.4(VWF):c.8113G>A (p.Gly2705Arg) variant in VWF is a missense variant predicted to cause substitution of Glycine by Arginine at amino acid 2705. The Grpmax filtering allele frequency in gnomAD v4.1 is 0.1227 (based on 11352/91062 alleles in the South Asian population, including 829 homozygotes), which is higher than the ClinGen VWD VCEP threshold of >0.1 for BA1. As reported in PMID: 26105150 the variant is significantly associated with lower plasma levels of FVIII but not vWF. In summary this variant is classified as Benign for VWD based on the ACMG/AMP criteria applied, as specified by the ClinGen VWD VCEP: BA1 -

von Willebrand disease type 2 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

von Willebrand disease type 3 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

von Willebrand disease type 1 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.41
BayesDel_addAF
Benign
-0.45
T
BayesDel_noAF
Benign
-0.32
CADD
Pathogenic
28
DANN
Pathogenic
1.0
DEOGEN2
Pathogenic
0.80
D
Eigen
Pathogenic
0.80
Eigen_PC
Pathogenic
0.74
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Uncertain
0.93
D
MetaRNN
Benign
0.0027
T
MetaSVM
Benign
-0.90
T
MutationAssessor
Pathogenic
3.1
M
PhyloP100
5.9
PrimateAI
Uncertain
0.50
T
PROVEAN
Uncertain
-3.6
D
REVEL
Uncertain
0.29
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Polyphen
1.0
D
Vest4
0.30
MutPred
0.39
Gain of catalytic residue at L2702 (P = 0.0017);
MPC
1.0
ClinPred
0.024
T
GERP RS
5.5
Varity_R
0.53
gMVP
0.93
Mutation Taster
=29/71
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.95
dbscSNV1_RF
Pathogenic
0.79
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7962217; hg19: chr12-6061559; COSMIC: COSV54621796; API